COMMUNIQUÉS West-GlobeNewswire

Skyline Medical Announces Pricing of Firm Commitment Public Offering of Common Stock and Warrants

05/01/2018 - 15:35

MINNEAPOLIS, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

APEIRON to Present at the Biotech Showcase™ Annual Conference on January 9, 2018

05/01/2018 - 15:30

VIENNA, Austria, Jan. 05, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 at the Hilton [...]

Radius Health to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 15:07

WALTHAM, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), today announced that President and Chief Executive Officer, Jesper Høiland, will present a corporate update at the 36th Annual J.P. [...]

OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

05/01/2018 - 15:00

WARSAW, Ind., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary [...]

bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference

05/01/2018 - 15:00

SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect and treat multiple [...]

Novan Announces Pricing of $38.0 Million Offering of Common Stock and Warrants

05/01/2018 - 15:00

MORRISVILLE, N.C., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced the pricing of the Company's underwritten offering of 10 million shares of its common stock and [...]

Burcon Announces Rights Offering

05/01/2018 - 14:36

VANCOUVER, British Columbia, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon ") is pleased to announce that it will be offering rights (the " Rights Offering ") to [...]

Agritek Holdings Inc. CEO B. Michael Friedman Issues Letter to Shareholders

05/01/2018 - 14:30

LOS ANGELES, CA, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®

05/01/2018 - 14:30

Anticipated Cost Savings of $7-$8 Million MORRISTOWN, N.J., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that, due to the [...]

Bavarian Nordic A/S - Articles of Association

05/01/2018 - 14:23

Updated Articles of Association for Bavarian Nordic A/S Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/899513cf-91d6-4ada-a6ca-a627649f9371

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

05/01/2018 - 14:05

TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company working to improve patient lives by providing high quality biologics manufacturing services [...]

Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

05/01/2018 - 14:01

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]

Momenta Pharmaceuticals Reports Positive Top-Line Phase 1 Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers

05/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported positive [...]

BeyondSpring to Present at the 10th Annual Biotech Showcase

05/01/2018 - 14:00

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development and commercialization of a [...]

Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017

05/01/2018 - 14:00

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) today reported that it achieved preliminary, unaudited revenue of approximately $3.9 million for the fourth quarter ended December [...]

Molecular Templates Provides Corporate Update and Outlines 2018 Milestones

05/01/2018 - 14:00

Takeda Nominated Two Targets Under Research Collaboration in Dec. 2017 Updated MT-3724 Clinical Results Expected in 1H18 At Least Two New MTEM Products to Enter the Clinic in 2018 AUSTIN, Texas, Jan. 05, 2018 (GLOBE [...]

Aduro Biotech Announces Management Changes

05/01/2018 - 14:00

BERKELEY, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) a biopharmaceutical company with three distinct immunotherapy technologies, today announced that Jennifer Lew has been promoted to [...]

Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

05/01/2018 - 14:00

Retrophin obtains exclusive option to purchase Censa post proof-of-concept study Phase 2 proof-of-concept study in PKU patients expected to commence in mid-2018 SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, [...]

Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner

05/01/2018 - 14:00

NEWTOWN, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]